Taiwan FDA registration fc401fb596ece8c0fd558d0046c84add
"100 first" human growth hormone radioimmunoassay reagents
TW: “百首”人體生長激素放射免疫分析試劑
Taiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Nov 11, 2009 – Nov 11, 2024ExpiredRegistration details
- Analysis ID
- fc401fb596ece8c0fd558d0046c84add
- Customs Code
- DHAS0602071508
Company information
- Manufacturer
- DIASOURCE IMMUNOASSAYS S.A.
- Manufacturer Country
- Belgium
- Authorized Representative
- TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
- Intended Use
- Radioimmunoassay reagent for the in vitro quantitative detection of growth hormone (hGH) in human serum
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- Imports must be accompanied by a letter of consent (a certificate of approval of the Atomic Energy Commission shall be attached to each batch of imports); input
Dates and status
- Registration Date
- Nov 11, 2009
- Expiry Date
- Nov 11, 2024
About this record
Access comprehensive regulatory information for "100 first" human growth hormone radioimmunoassay reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fc401fb596ece8c0fd558d0046c84add and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices